AMGEN at AHA

AHA Scientific Sessions 2021

November 13–15, 2021, Virtual

Amgen is proud to be part of the American Heart Association Scientific Sessions 2021. While you're here, you can explore the latest scientific information and disease state education from Amgen, and learn about Amgen's long-term commitment to developing and delivering transformative medicines for patients with cardiovascular disease.

Amgen | A Worldwide Pioneer in Biotechnology

Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing, and delivering innovative human therapeutics. A biotechnology pioneer since 1980, Amgen has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.
For more information, visit www.amgen.com and follow us on www.twitter.com/amgen.